For Teneurin-2, further data supported an early time point for expression changes in carcinogenesis of the breast (Lee et al., 2007), while in cervical cancer, RNA levels decreased in advanced stages with nodal compromise or the presence of metastasis (Noordhuis et al., 2011). The gene discussed is TENM2; the disease is cervical carcinoma.